Biotechnology Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 26-Jan-2022
No. of pages: 67

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies.

This report contains market size and forecasts of Biotechnology in Global, including the following market information:

Global Biotechnology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biotechnology market was valued at 528940 million in 2021 and is projected to reach US$ 856060 million by 2028, at a CAGR of 7.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

DNA Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biotechnology include Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Pfizer, Merck &, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biotechnology Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biotechnology Market Segment Percentages, by Type, 2021 (%)

- DNA Sequencing

- Nanobiotechnology

- Tissue engineering and Regeneration

- Fermentation

- Cell Based Assay

- PCR Technology

- Chromatography Market

- Others

Global Biotechnology Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biotechnology Market Segment Percentages, by Application, 2021 (%)

- Health

- Food & Agriculture

- Natural Resources & Environment

- Industrial Processing

- Bioinformatics

- Others

Global Biotechnology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biotechnology Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biotechnology revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biotechnology revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Johnson & Johnson Services, Inc.

- F. Hoffmann-La Roche Ltd

- Pfizer

- Merck &

- Sanofi

- AstraZeneca

- Gilead

- CELGENE CORPORATION

- Biogen

- Amgen, Inc

- Abbott

- Novo Nordisk A/S

- Novartis AG

- Lonza

Biotechnology Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biotechnology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biotechnology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biotechnology Overall Market Size
2.1 Global Biotechnology Market Size: 2021 VS 2028
2.2 Global Biotechnology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biotechnology Players in Global Market
3.2 Top Global Biotechnology Companies Ranked by Revenue
3.3 Global Biotechnology Revenue by Companies
3.4 Top 3 and Top 5 Biotechnology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biotechnology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biotechnology Players in Global Market
3.6.1 List of Global Tier 1 Biotechnology Companies
3.6.2 List of Global Tier 2 and Tier 3 Biotechnology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biotechnology Market Size Markets, 2021 & 2028
4.1.2 DNA Sequencing
4.1.3 Nanobiotechnology
4.1.4 Tissue engineering and Regeneration
4.1.5 Fermentation
4.1.6 Cell Based Assay
4.1.7 PCR Technology
4.1.8 Chromatography Market
4.1.9 Others
4.2 By Type - Global Biotechnology Revenue & Forecasts
4.2.1 By Type - Global Biotechnology Revenue, 2017-2022
4.2.2 By Type - Global Biotechnology Revenue, 2023-2028
4.2.3 By Type - Global Biotechnology Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biotechnology Market Size, 2021 & 2028
5.1.2 Health
5.1.3 Food & Agriculture
5.1.4 Natural Resources & Environment
5.1.5 Industrial Processing
5.1.6 Bioinformatics
5.1.7 Others
5.2 By Application - Global Biotechnology Revenue & Forecasts
5.2.1 By Application - Global Biotechnology Revenue, 2017-2022
5.2.2 By Application - Global Biotechnology Revenue, 2023-2028
5.2.3 By Application - Global Biotechnology Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biotechnology Market Size, 2021 & 2028
6.2 By Region - Global Biotechnology Revenue & Forecasts
6.2.1 By Region - Global Biotechnology Revenue, 2017-2022
6.2.2 By Region - Global Biotechnology Revenue, 2023-2028
6.2.3 By Region - Global Biotechnology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biotechnology Revenue, 2017-2028
6.3.2 US Biotechnology Market Size, 2017-2028
6.3.3 Canada Biotechnology Market Size, 2017-2028
6.3.4 Mexico Biotechnology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biotechnology Revenue, 2017-2028
6.4.2 Germany Biotechnology Market Size, 2017-2028
6.4.3 France Biotechnology Market Size, 2017-2028
6.4.4 U.K. Biotechnology Market Size, 2017-2028
6.4.5 Italy Biotechnology Market Size, 2017-2028
6.4.6 Russia Biotechnology Market Size, 2017-2028
6.4.7 Nordic Countries Biotechnology Market Size, 2017-2028
6.4.8 Benelux Biotechnology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biotechnology Revenue, 2017-2028
6.5.2 China Biotechnology Market Size, 2017-2028
6.5.3 Japan Biotechnology Market Size, 2017-2028
6.5.4 South Korea Biotechnology Market Size, 2017-2028
6.5.5 Southeast Asia Biotechnology Market Size, 2017-2028
6.5.6 India Biotechnology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biotechnology Revenue, 2017-2028
6.6.2 Brazil Biotechnology Market Size, 2017-2028
6.6.3 Argentina Biotechnology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biotechnology Revenue, 2017-2028
6.7.2 Turkey Biotechnology Market Size, 2017-2028
6.7.3 Israel Biotechnology Market Size, 2017-2028
6.7.4 Saudi Arabia Biotechnology Market Size, 2017-2028
6.7.5 UAE Biotechnology Market Size, 2017-2028
7 Players Profiles
7.1 Johnson & Johnson Services, Inc.
7.1.1 Johnson & Johnson Services, Inc. Corporate Summary
7.1.2 Johnson & Johnson Services, Inc. Business Overview
7.1.3 Johnson & Johnson Services, Inc. Biotechnology Major Product Offerings
7.1.4 Johnson & Johnson Services, Inc. Biotechnology Revenue in Global Market (2017-2022)
7.1.5 Johnson & Johnson Services, Inc. Key News
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.2.2 F. Hoffmann-La Roche Ltd Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Biotechnology Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd Biotechnology Revenue in Global Market (2017-2022)
7.2.5 F. Hoffmann-La Roche Ltd Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Biotechnology Major Product Offerings
7.3.4 Pfizer Biotechnology Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Merck &
7.4.1 Merck & Corporate Summary
7.4.2 Merck & Business Overview
7.4.3 Merck & Biotechnology Major Product Offerings
7.4.4 Merck & Biotechnology Revenue in Global Market (2017-2022)
7.4.5 Merck & Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Biotechnology Major Product Offerings
7.5.4 Sanofi Biotechnology Revenue in Global Market (2017-2022)
7.5.5 Sanofi Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Biotechnology Major Product Offerings
7.6.4 AstraZeneca Biotechnology Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Gilead
7.7.1 Gilead Corporate Summary
7.7.2 Gilead Business Overview
7.7.3 Gilead Biotechnology Major Product Offerings
7.7.4 Gilead Biotechnology Revenue in Global Market (2017-2022)
7.7.5 Gilead Key News
7.8 CELGENE CORPORATION
7.8.1 CELGENE CORPORATION Corporate Summary
7.8.2 CELGENE CORPORATION Business Overview
7.8.3 CELGENE CORPORATION Biotechnology Major Product Offerings
7.8.4 CELGENE CORPORATION Biotechnology Revenue in Global Market (2017-2022)
7.8.5 CELGENE CORPORATION Key News
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Biotechnology Major Product Offerings
7.9.4 Biogen Biotechnology Revenue in Global Market (2017-2022)
7.9.5 Biogen Key News
7.10 Amgen, Inc
7.10.1 Amgen, Inc Corporate Summary
7.10.2 Amgen, Inc Business Overview
7.10.3 Amgen, Inc Biotechnology Major Product Offerings
7.10.4 Amgen, Inc Biotechnology Revenue in Global Market (2017-2022)
7.10.5 Amgen, Inc Key News
7.11 Abbott
7.11.1 Abbott Corporate Summary
7.11.2 Abbott Business Overview
7.11.3 Abbott Biotechnology Major Product Offerings
7.11.4 Abbott Biotechnology Revenue in Global Market (2017-2022)
7.11.5 Abbott Key News
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Corporate Summary
7.12.2 Novo Nordisk A/S Business Overview
7.12.3 Novo Nordisk A/S Biotechnology Major Product Offerings
7.12.4 Novo Nordisk A/S Biotechnology Revenue in Global Market (2017-2022)
7.12.5 Novo Nordisk A/S Key News
7.13 Novartis AG
7.13.1 Novartis AG Corporate Summary
7.13.2 Novartis AG Business Overview
7.13.3 Novartis AG Biotechnology Major Product Offerings
7.13.4 Novartis AG Biotechnology Revenue in Global Market (2017-2022)
7.13.5 Novartis AG Key News
7.14 Lonza
7.14.1 Lonza Corporate Summary
7.14.2 Lonza Business Overview
7.14.3 Lonza Biotechnology Major Product Offerings
7.14.4 Lonza Biotechnology Revenue in Global Market (2017-2022)
7.14.5 Lonza Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Biotechnology Market Opportunities & Trends in Global Market
Table 2. Biotechnology Market Drivers in Global Market
Table 3. Biotechnology Market Restraints in Global Market
Table 4. Key Players of Biotechnology in Global Market
Table 5. Top Biotechnology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biotechnology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biotechnology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biotechnology Product Type
Table 9. List of Global Tier 1 Biotechnology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biotechnology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Biotechnology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biotechnology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biotechnology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Biotechnology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biotechnology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biotechnology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Biotechnology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biotechnology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biotechnology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biotechnology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biotechnology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biotechnology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biotechnology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biotechnology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biotechnology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biotechnology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biotechnology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biotechnology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biotechnology Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Services, Inc. Corporate Summary
Table 31. Johnson & Johnson Services, Inc. Biotechnology Product Offerings
Table 32. Johnson & Johnson Services, Inc. Biotechnology Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd Biotechnology Product Offerings
Table 35. F. Hoffmann-La Roche Ltd Biotechnology Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Biotechnology Product Offerings
Table 38. Pfizer Biotechnology Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Corporate Summary
Table 40. Merck & Biotechnology Product Offerings
Table 41. Merck & Biotechnology Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Biotechnology Product Offerings
Table 44. Sanofi Biotechnology Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Biotechnology Product Offerings
Table 47. AstraZeneca Biotechnology Revenue (US$, Mn), (2017-2022)
Table 48. Gilead Corporate Summary
Table 49. Gilead Biotechnology Product Offerings
Table 50. Gilead Biotechnology Revenue (US$, Mn), (2017-2022)
Table 51. CELGENE CORPORATION Corporate Summary
Table 52. CELGENE CORPORATION Biotechnology Product Offerings
Table 53. CELGENE CORPORATION Biotechnology Revenue (US$, Mn), (2017-2022)
Table 54. Biogen Corporate Summary
Table 55. Biogen Biotechnology Product Offerings
Table 56. Biogen Biotechnology Revenue (US$, Mn), (2017-2022)
Table 57. Amgen, Inc Corporate Summary
Table 58. Amgen, Inc Biotechnology Product Offerings
Table 59. Amgen, Inc Biotechnology Revenue (US$, Mn), (2017-2022)
Table 60. Abbott Corporate Summary
Table 61. Abbott Biotechnology Product Offerings
Table 62. Abbott Biotechnology Revenue (US$, Mn), (2017-2022)
Table 63. Novo Nordisk A/S Corporate Summary
Table 64. Novo Nordisk A/S Biotechnology Product Offerings
Table 65. Novo Nordisk A/S Biotechnology Revenue (US$, Mn), (2017-2022)
Table 66. Novartis AG Corporate Summary
Table 67. Novartis AG Biotechnology Product Offerings
Table 68. Novartis AG Biotechnology Revenue (US$, Mn), (2017-2022)
Table 69. Lonza Corporate Summary
Table 70. Lonza Biotechnology Product Offerings
Table 71. Lonza Biotechnology Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biotechnology Segment by Type in 2021
Figure 2. Biotechnology Segment by Application in 2021
Figure 3. Global Biotechnology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biotechnology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biotechnology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biotechnology Revenue in 2021
Figure 8. By Type - Global Biotechnology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biotechnology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biotechnology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biotechnology Revenue Market Share, 2017-2028
Figure 12. US Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biotechnology Revenue Market Share, 2017-2028
Figure 16. Germany Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 17. France Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biotechnology Revenue Market Share, 2017-2028
Figure 24. China Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 28. India Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biotechnology Revenue Market Share, 2017-2028
Figure 30. Brazil Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biotechnology Revenue Market Share, 2017-2028
Figure 33. Turkey Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Services, Inc. Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gilead Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. CELGENE CORPORATION Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogen Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen, Inc Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Abbott Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novo Nordisk A/S Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis AG Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lonza Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs